- Home
- PCT vs RCKT Comparison
PCT vs RCKT Comparison
Compare PCT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCT | RCKT |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 394.2M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PCT | RCKT |
|---|---|---|
| Price | $5.65 | $3.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $13.00 | ★ $29.73 |
| AVG Volume (30 Days) | ★ 3.0M | 1.4M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.86 | 26.37 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $8,355,000.00 | N/A |
| Revenue This Year | $380.44 | N/A |
| Revenue Next Year | $203.33 | $64.28 |
| P/E Ratio | ★ N/A | $5.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.93 | $2.53 |
| 52 Week High | $15.49 | $5.45 |
Technical Indicators
Market Signals| Indicator | PCT | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 32.46 | N/A |
| Support Level | $5.02 | N/A |
| Resistance Level | $6.23 | N/A |
| Average True Range (ATR) | 0.34 | 0.00 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 5.76 | 0.00 |
Price Performance
Historical ComparisonAbout PCT PureCycle Technologies Inc.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.